{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:30:56Z","timestamp":1772119856055,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T00:00:00Z","timestamp":1648166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11102-022-01217-z","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T11:21:41Z","timestamp":1648207301000},"page":"480-485","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Growth hormone secreting pituitary adenomas show distinct extrasellar extension patterns compared to nonfunctional pituitary adenomas"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7391-9825","authenticated-orcid":false,"given":"Dhiraj J.","family":"Pangal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark S.","family":"Shiroishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Ruzevick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Zada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,3,25]]},"reference":[{"key":"1217_CR1","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1056\/NEJMra1810772","volume":"382","author":"S Melmed","year":"2020","unstructured":"Melmed S (2020) Pituitary-tumor endocrinopathies. N Engl J Med 382:937\u2013950. https:\/\/doi.org\/10.1056\/NEJMra1810772","journal-title":"N Engl J Med"},{"key":"1217_CR2","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/2014.5.JNS131819","volume":"121","author":"H Gittleman","year":"2014","unstructured":"Gittleman H, Ostrom QT, Farah PD et al (2014) Descriptive epidemiology of pituitary tumors in the United States, 2004\u20132009. J Neurosurg 121:527\u2013535. https:\/\/doi.org\/10.3171\/2014.5.JNS131819","journal-title":"J Neurosurg"},{"key":"1217_CR3","doi-asserted-by":"publisher","unstructured":"Fleseriu M, F\u00fchrer-Sakel D, van der Lely AJ, et al (2021) More than a decade of real-world experience of pegvisomant for acromegaly: ACROSTUDY. Eur J Endocrinol EJE-21-0239.R1. https:\/\/doi.org\/10.1530\/EJE-21-0239","DOI":"10.1530\/EJE-21-0239"},{"key":"1217_CR4","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.3390\/jcm10071377","volume":"10","author":"A Bogus\u0142awska","year":"2021","unstructured":"Bogus\u0142awska A, Korbonits M (2021) Genetics of acromegaly and gigantism. J Clin Med 10:1377. https:\/\/doi.org\/10.3390\/jcm10071377","journal-title":"J Clin Med"},{"key":"1217_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2147\/TCRM.S183360","volume":"16","author":"G Corica","year":"2020","unstructured":"Corica G, Ceraudo M, Campana C et al (2020) Octreotide-resistant acromegaly: challenges and solutions. Ther Clin Risk Manag 16:379\u2013391. https:\/\/doi.org\/10.2147\/TCRM.S183360","journal-title":"Ther Clin Risk Manag"},{"key":"1217_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1210\/er.2010-0002","volume":"32","author":"A Colao","year":"2011","unstructured":"Colao A, Auriemma RS, Lombardi G, Pivonello R (2011) Resistance to somatostatin analogs in acromegaly. Endocr Rev 32:247\u2013271. https:\/\/doi.org\/10.1210\/er.2010-0002","journal-title":"Endocr Rev"},{"key":"1217_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s11102-016-0737-y","volume":"20","author":"DST Lim","year":"2017","unstructured":"Lim DST, Fleseriu M (2017) The role of combination medical therapy in the treatment of acromegaly. Pituitary 20:136\u2013148. https:\/\/doi.org\/10.1007\/s11102-016-0737-y","journal-title":"Pituitary"},{"key":"1217_CR8","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1210\/jc.2013-3054","volume":"99","author":"E Monsalves","year":"2014","unstructured":"Monsalves E, Larjani S, Loyola Godoy B et al (2014) Growth patterns of pituitary adenomas and histopathological correlates. J Clin Endocrinol Metab 99:1330\u20131338. https:\/\/doi.org\/10.1210\/jc.2013-3054","journal-title":"J Clin Endocrinol Metab"},{"key":"1217_CR9","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2010.7.FOCUS10155","volume":"29","author":"G Zada","year":"2010","unstructured":"Zada G, Lin N, Laws ER (2010) Patterns of extrasellar extension in growth hormone-secreting and nonfunctional pituitary macroadenomas. Neurosurg Focus 29:E4. https:\/\/doi.org\/10.3171\/2010.7.FOCUS10155","journal-title":"Neurosurg Focus"},{"key":"1217_CR10","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1148\/radiol.2282020695","volume":"228","author":"A Hagiwara","year":"2003","unstructured":"Hagiwara A, Inoue Y, Wakasa K et al (2003) Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: imaging characteristics and pathologic correlation. Radiology 228:533\u2013538. https:\/\/doi.org\/10.1148\/radiol.2282020695","journal-title":"Radiology"},{"key":"1217_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013617. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"1217_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed S, Bronstein MD, Chanson P et al (2018) A Consensus Statement on acromegaly therapeutic outcomes. Nat Rev Endocrinol 14:552\u2013561. https:\/\/doi.org\/10.1038\/s41574-018-0058-5","journal-title":"Nat Rev Endocrinol"},{"key":"1217_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11102-016-0782-6","volume":"20","author":"E Kuhn","year":"2017","unstructured":"Kuhn E, Chanson P (2017) Cabergoline in acromegaly. Pituitary 20:121\u2013128. https:\/\/doi.org\/10.1007\/s11102-016-0782-6","journal-title":"Pituitary"},{"key":"1217_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s11102-016-0781-7","volume":"20","author":"DA Donoho","year":"2017","unstructured":"Donoho DA, Bose N, Zada G, Carmichael JD (2017) Management of aggressive growth hormone secreting pituitary adenomas. Pituitary 20:169\u2013178. https:\/\/doi.org\/10.1007\/s11102-016-0781-7","journal-title":"Pituitary"},{"key":"1217_CR15","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355:2558\u20132573. https:\/\/doi.org\/10.1056\/NEJMra062453","journal-title":"N Engl J Med"},{"key":"1217_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s12902-016-0096-8","volume":"16","author":"MD Bronstein","year":"2016","unstructured":"Bronstein MD, Fleseriu M, Neggers S et al (2016) Switching patients with acromegaly from octreotide to pasireotide improves biochemical control: crossover extension to a randomized, double-blind, Phase III study. BMC Endocr Disord 16:16. https:\/\/doi.org\/10.1186\/s12902-016-0096-8","journal-title":"BMC Endocr Disord"},{"key":"1217_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s11102-013-0479-z","volume":"17","author":"Y Bakhtiar","year":"2014","unstructured":"Bakhtiar Y, Hanaya R, Tokimura H et al (2014) Geometric survey on magnetic resonance imaging of growth hormone producing pituitary adenoma. Pituitary 17:142\u2013149. https:\/\/doi.org\/10.1007\/s11102-013-0479-z","journal-title":"Pituitary"},{"key":"1217_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/cen.13064","volume":"85","author":"M Gruppetta","year":"2016","unstructured":"Gruppetta M, Vassallo J (2016) Epidemiology and radiological geometric assessment of pituitary macroadenomas: population-based study. Clin Endocrinol 85:223\u2013231. https:\/\/doi.org\/10.1111\/cen.13064","journal-title":"Clin Endocrinol"},{"key":"1217_CR19","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1210\/jc.2014-2468","volume":"100","author":"D Cuevas-Ramos","year":"2015","unstructured":"Cuevas-Ramos D, Carmichael JD, Cooper O et al (2015) A structural and functional acromegaly classification. J Clin Endocrinol Metab 100:122\u2013131. https:\/\/doi.org\/10.1210\/jc.2014-2468","journal-title":"J Clin Endocrinol Metab"},{"key":"1217_CR20","doi-asserted-by":"publisher","first-page":"454","DOI":"10.3171\/jns.1979.50.4.0454","volume":"50","author":"ER Laws","year":"1979","unstructured":"Laws ER, Piepgras DG, Randall RV, Abboud CF (1979) Neurosurgical management of acromegaly. Results in 82 patients treated between 1972 and 1977. J Neurosurg 50:454\u2013461. https:\/\/doi.org\/10.3171\/jns.1979.50.4.0454","journal-title":"J Neurosurg"},{"key":"1217_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3171\/JNS\/2008\/108\/3\/0525","volume":"108","author":"M Losa","year":"2008","unstructured":"Losa M, Mortini P, Barzaghi R et al (2008) Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108:525\u2013532. https:\/\/doi.org\/10.3171\/JNS\/2008\/108\/3\/0525","journal-title":"J Neurosurg"},{"key":"1217_CR22","doi-asserted-by":"publisher","first-page":"S150","DOI":"10.21037\/gs.2019.06.04","volume":"8","author":"F Tortora","year":"2019","unstructured":"Tortora F, Negro A, Grasso LFS et al (2019) Pituitary magnetic resonance imaging predictive role in the therapeutic response of growth hormone-secreting pituitary adenomas. Gland Surg 8:S150\u2013S158. https:\/\/doi.org\/10.21037\/gs.2019.06.04","journal-title":"Gland Surg"},{"key":"1217_CR23","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1038\/s41598-018-24260-y","volume":"8","author":"MR Alhambra-Exp\u00f3sito","year":"2018","unstructured":"Alhambra-Exp\u00f3sito MR, Ib\u00e1\u00f1ez-Costa A, Moreno-Moreno P et al (2018) Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas. Sci Rep 8:6173. https:\/\/doi.org\/10.1038\/s41598-018-24260-y","journal-title":"Sci Rep"},{"key":"1217_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s11102-017-0788-8","volume":"20","author":"I Potorac","year":"2017","unstructured":"Potorac I, Beckers A, Bonneville J-F (2017) T2-weighted MRI signal intensity as a predictor of hormonal and tumoral responses to somatostatin receptor ligands in acromegaly: a perspective. Pituitary 20:116\u2013120. https:\/\/doi.org\/10.1007\/s11102-017-0788-8","journal-title":"Pituitary"},{"key":"1217_CR25","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3171\/jns.2003.98.2.0350","volume":"98","author":"G Zada","year":"2003","unstructured":"Zada G, Kelly DF, Cohan P et al (2003) Endonasal transsphenoidal approach for pituitary adenomas and other sellar lesions: an assessment of efficacy, safety, and patient impressions. J Neurosurg 98:350\u2013358. https:\/\/doi.org\/10.3171\/jns.2003.98.2.0350","journal-title":"J Neurosurg"},{"key":"1217_CR26","doi-asserted-by":"publisher","first-page":"101513","DOI":"10.1016\/j.beem.2021.101513","volume":"35","author":"R Senanayake","year":"2021","unstructured":"Senanayake R, Gillett D, MacFarlane J et al (2021) New types of localization methods for adrenocorticotropic hormone-dependent Cushing\u2019s syndrome. Best Pract Res Clin Endocrinol Metab 35:101513. https:\/\/doi.org\/10.1016\/j.beem.2021.101513","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"1217_CR27","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s1470-2045(01)00622-2","volume":"3","author":"IJ Fidler","year":"2002","unstructured":"Fidler IJ, Yano S, Zhang R-D et al (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3:53\u201357. https:\/\/doi.org\/10.1016\/s1470-2045(01)00622-2","journal-title":"Lancet Oncol"},{"key":"1217_CR28","doi-asserted-by":"publisher","first-page":"722917","DOI":"10.3389\/fcell.2021.722917","volume":"9","author":"Z Guan","year":"2021","unstructured":"Guan Z, Lan H, Cai X et al (2021) Blood-brain barrier, cell junctions, and tumor microenvironment in brain metastases, the biological prospects and dilemma in therapies. Front Cell Dev Biol 9:722917. https:\/\/doi.org\/10.3389\/fcell.2021.722917","journal-title":"Front Cell Dev Biol"},{"key":"1217_CR29","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1073\/pnas.1322098111","volume":"111","author":"J Neman","year":"2014","unstructured":"Neman J, Termini J, Wilczynski S et al (2014) Human breast cancer metastases to the brain display GABAergic properties in the neural niche. Proc Natl Acad Sci USA 111:984\u2013989. https:\/\/doi.org\/10.1073\/pnas.1322098111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"1217_CR30","doi-asserted-by":"publisher","first-page":"00494","DOI":"10.1016\/j.ccell.2021.09.005","volume":"S1535\u20136108","author":"Y Kfoury","year":"2021","unstructured":"Kfoury Y, Baryawno N, Severe N et al (2021) Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment. Cancer Cell S1535\u20136108(21):00494\u201300503. https:\/\/doi.org\/10.1016\/j.ccell.2021.09.005","journal-title":"Cancer Cell"},{"key":"1217_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00539-0","author":"MC Masone","year":"2021","unstructured":"Masone MC (2021) Bone marrow microenvironment in prostate cancer. Nat Rev Urol. https:\/\/doi.org\/10.1038\/s41585-021-00539-0","journal-title":"Nat Rev Urol"},{"key":"1217_CR32","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R et al (2020) Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37:123-134.e5. https:\/\/doi.org\/10.1016\/j.ccell.2019.11.002","journal-title":"Cancer Cell"},{"key":"1217_CR33","doi-asserted-by":"publisher","first-page":"5738","DOI":"10.1172\/JCI138540","volume":"130","author":"A Ben-Shlomo","year":"2020","unstructured":"Ben-Shlomo A, Deng N, Ding E et al (2020) DNA damage and growth hormone hypersecretion in pituitary somatotroph adenomas. J Clin Invest 130:5738\u20135755. https:\/\/doi.org\/10.1172\/JCI138540","journal-title":"J Clin Invest"},{"key":"1217_CR34","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10014-017-0307-7","volume":"35","author":"H Nishioka","year":"2018","unstructured":"Nishioka H, Inoshita N (2018) New WHO classification of pituitary adenomas (4th edition): assessment of pituitary transcription factors and the prognostic histological factors. Brain Tumor Pathol 35:57\u201361. https:\/\/doi.org\/10.1007\/s10014-017-0307-7","journal-title":"Brain Tumor Pathol"},{"key":"1217_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1017\/cjn.2017.203","volume":"44","author":"SA Imran","year":"2017","unstructured":"Imran SA, Shankar J, Hebb ALO et al (2017) Radiological growth patterns of prolactinomas and nonfunctioning adenomas. Can J Neurol Sci 44:508\u2013513. https:\/\/doi.org\/10.1017\/cjn.2017.203","journal-title":"Can J Neurol Sci"},{"key":"1217_CR36","doi-asserted-by":"publisher","first-page":"106942","DOI":"10.1016\/j.clineuro.2021.106942","volume":"209","author":"G Sharifi","year":"2021","unstructured":"Sharifi G, Sabahi M, Amin A et al (2021) Patterns of extrasellar invasive growth of pituitary adenomas with normal sellar cavity size. Clin Neurol Neurosurg 209:106942. https:\/\/doi.org\/10.1016\/j.clineuro.2021.106942","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01217-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-022-01217-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-022-01217-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T17:08:11Z","timestamp":1654535291000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-022-01217-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,25]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1217"],"URL":"https:\/\/doi.org\/10.1007\/s11102-022-01217-z","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742180152.793595866","asserted-by":"object"}]},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"value":"1386-341X","type":"print"},{"value":"1573-7403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,25]]},"assertion":[{"value":"10 March 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no potential conflicts of interest to disclose. The study was approved by the IRB at our institution, and patient consent was waived given the retrospective and anonymized nature of the data analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board of the University of Southern California and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants, their data or biological material"}}]}}